Somaxon Pharmaceuticals ( SOMX)

Drug/indication: Silenor for insomnia

Approval decision date: March 21

The FDA issued a complete response letter for Silenor last December. Somaxon met with the FDA, submitted additional information about the drug's effect in non-elderly patients and now says the agency has all the data it needs to review the drug and issue an approval decision.

If you liked this article you might like

Ardelyx Has Big Potential

Ardelyx Has Big Potential

Biotech M&A Waking Up After Long Nap

Biotech M&A Waking Up After Long Nap

Xenoport's Cost-Cutting Tactics Lead to Buyout With Hefty Premium

Here's Why XenoPort (XNPT) Stock is Continuing to Surge Today

Trending Tickers: XNPT, OLED, MON, TPUB

Trending Tickers: XNPT, OLED, MON, TPUB